...
首页> 外文期刊>Journal of molecular modeling >Molecular docking and molecular dynamics studies reveal structural basis of inhibition and selectivity of inhibitors EGCG and OSU-03012 toward glucose regulated protein-78 (GRP78) overexpressed in glioblastoma
【24h】

Molecular docking and molecular dynamics studies reveal structural basis of inhibition and selectivity of inhibitors EGCG and OSU-03012 toward glucose regulated protein-78 (GRP78) overexpressed in glioblastoma

机译:分子对接和分子动力学研究揭示了胶质母细胞瘤中抑制剂EGCG和OSU-03012对过表达的葡萄糖调节蛋白78(GRP78)的抑制作用和选择性的结构基础

获取原文
获取原文并翻译 | 示例
           

摘要

Glioblastoma (GBM), a malignant form of brain tumor, has a high mortality rate. GRP78, one of the HSP70 protein family members, is overexpressed in GBM. GRP78 is the key chaperone protein involved in the unfolded protein response. Upregulated GRP78 expression in cancer cells inhibits apoptosis and promotes chemoresistance. GRP78 has an ATPase domain, a substrate-binding domain, and a linker region. ATP-competitive inhibitors such as EGCG and OSU-03012 inhibit GRP78 activity and reduce its expression in GBM. However, there is a lack of structural data on the binding modes of these inhibitors to GRP78 ATPase domain. Further, the mode of selectivity of these inhibitors toward GRP78 also is unknown. Toward this end, molecular docking was performed with AutoDock Vina and confirmation obtained by docking using ROSIE. The stability and MM-PBSA binding energy of GRP78-inhibitor complexes as well as energetic contribution of individual residues was analyzed by 50 ns molecular dynamics run with GROMACS. MSA by ClustalW2 identified unique amino acid residues in the ATPase domain of GRP78 which were different from the residues present in other HSP70 proteins. Important and unique amino acid residues of GRP78 such as Ile61, Glu293, Arg297, and Arg367 played a major role in the intermolecular interactions with these inhibitors. The interactions with unique residues of GRP78 as compared with those of HSP70-1A provided the basis for selectivity. It was found that the binding affinity and specificity/selectivity of EGCG toward GRP78 was higher than that toward HSP70-1A, and selectivity was even better than OSU-03012. OSU-03012 was predicted to bind to GRP78. Analyses from MD runs showed tight binding and stability of complexes, and the highest number of hydrogen bonds during the trajectory runs were comparable to those found in the docking studies. Energetic contribution of individual inhibitor-interacting residues showed that energy values of Ile61 and Glu293 were among the most negative. These studies are, to the best of our knowledge, the first studies characterizing EGCG and OSU-03012 interactions with GRP78 on a structural basis and provide a significant insight into their binding modes, selectivity, and structural stability.
机译:胶质母细胞瘤(GBM)是脑肿瘤的恶性形式,死亡率很高。 HRP70蛋白家族成员之一GRP78在GBM中过表达。 GRP78是参与展开的蛋白质反应的关键伴侣蛋白。癌细胞中GRP78表达的上调抑制了细胞凋亡并促进了化学抗性。 GRP78具有ATPase结构域,底物结合结构域和接头区域。 ATP竞争性抑制剂(例如EGCG和OSU-03012)抑制GRP78活性并降低其在GBM中的表达。然而,关于这些抑制剂与GRP78 ATPase结构域的结合模式缺乏结构数据。此外,这些抑制剂对GRP78的选择性模式也是未知的。为此,使用AutoDock Vina进行分子对接,并使用ROSIE对接进行确认。通过使用GROMACS进行的50 ns分子动力学分析了GRP78-抑制剂复合物的稳定性和MM-PBSA结合能以及各个残基的能量贡献。 ClustalW2的MSA在GRP78的ATPase域中鉴定出独特的氨基酸残基,该残基不同于其他HSP70蛋白中存在的残基。 GRP78的重要且独特的氨基酸残基,例如Ile61,Glu293,Arg297和Arg367,在与这些抑制剂的分子间相互作用中起主要作用。与HSP70-1A相比,与GRP78独特残基的相互作用为选择性提供了基础。发现EGCG对GRP78的结合亲和力和特异性/选择性高于对HSP70-1A的结合亲和力和特异性/选择性,甚至比OSU-03012更好。预测OSU-03012与GRP78结合。 MD运行的分析表明配合物具有紧密的结合和稳定性,并且在轨迹运行期间氢键的最高数量与对接研究中发现的相当。单个与抑制剂相互作用的残基的能量贡献显示Ile61和Glu293的能量值是最负的。据我们所知,这些研究是第一批以结构为基础表征EGCG和OSU-03012与GRP78相互作用的研究,并对它们的结合方式,选择性和结构稳定性提供了重要的见识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号